Cargando…
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538064/ https://www.ncbi.nlm.nih.gov/pubmed/33092998 http://dx.doi.org/10.1016/j.dld.2020.10.001 |
| _version_ | 1783590791607746560 |
|---|---|
| author | Hariyanto, Timotius Ivan Prasetya, Ignatius Bima Kurniawan, Andree |
| author_facet | Hariyanto, Timotius Ivan Prasetya, Ignatius Bima Kurniawan, Andree |
| author_sort | Hariyanto, Timotius Ivan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7538064 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75380642020-10-07 Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection Hariyanto, Timotius Ivan Prasetya, Ignatius Bima Kurniawan, Andree Dig Liver Dis Correspondence Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2020-12 2020-10-06 /pmc/articles/PMC7538064/ /pubmed/33092998 http://dx.doi.org/10.1016/j.dld.2020.10.001 Text en © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Hariyanto, Timotius Ivan Prasetya, Ignatius Bima Kurniawan, Andree Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection |
| title | Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection |
| title_full | Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection |
| title_fullStr | Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection |
| title_full_unstemmed | Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection |
| title_short | Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection |
| title_sort | proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (covid-19) infection |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538064/ https://www.ncbi.nlm.nih.gov/pubmed/33092998 http://dx.doi.org/10.1016/j.dld.2020.10.001 |
| work_keys_str_mv | AT hariyantotimotiusivan protonpumpinhibitoruseisassociatedwithincreasedriskofseverityandmortalityfromcoronavirusdisease2019covid19infection AT prasetyaignatiusbima protonpumpinhibitoruseisassociatedwithincreasedriskofseverityandmortalityfromcoronavirusdisease2019covid19infection AT kurniawanandree protonpumpinhibitoruseisassociatedwithincreasedriskofseverityandmortalityfromcoronavirusdisease2019covid19infection |